ELENA KALABUSHKINA: Open Payments
NPI 1851902290 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,037 in 196 payments from 22 companies in 2025. Trend: 2023 $3,737 · 2024 $3,496 · 2025 $3,037
Food & beverage: $2,787Education: $250
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 35 | $450 |
| UCB, Inc. | 23 | $321 |
| Janssen Biotech, Inc. | 16 | $314 |
| Regeneron Healthcare Solutions, Inc. | 13 | $296 |
| ABBVIE INC. | 21 | $283 |
| Lilly USA, LLC | 14 | $215 |
| Galderma Laboratories, L.P. | 16 | $208 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $168 |
| Amgen Inc. | 12 | $162 |
| Incyte Corporation | 8 | $140 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, COSENTYX, NEMLUVIO, TALTZ, OTEZLA.
Industry payments across NY — which companies pay providers there.
